News
Hosted on MSN14h
Viruses can work where antibiotics don't—new research tells us more about how they fight bacteriaMuch like our bodies have immune mechanisms to fight off viruses, bacteria have also evolved defenses against phage infections. One such defense are "clustered regularly interspaced short palindromic ...
Bacteria and their phage, “are full of mysteries and also lots of really powerful mechanisms that we can study and potentially harness.” ...
Gut contains millions of tiny viruses that actually help keep you healthy by controlling harmful bacteria and supporting your ...
An alternative mechanism for recruiting Cas2/3 in a phage-encoded CRISPR–Cas system In type I-F CRISPR–Cas systems, Cas2/3 is typically recruited to the interference complex Cascade by Cas8f.
Shares of CRISPR Therapeutics CRSP have risen 14% over the past month, likely driven by encouraging results from the first candidates in its in vivo pipeline. CRSP’s Positive In Vivo Therapy ...
More information: Jihwan Yu et al, Programmable RNA acetylation with CRISPR–Cas13, Nature Chemical Biology (2025). DOI: 10.1038/s41589-025-01922-3 Journal information: Nature Chemical Biology ...
Victoria Gray, the first person cured of sickle cell using CRISPR gene editing therapies, spoke in Fargo about her journey and the need to lower the $2M treatment cost.
For the first time, scientists have successfully edited oat DNA, a breakthrough that could accelerate the development of oats with more fiber, higher yields, and greater resilience to climate change.
The patents involved, U.S. Patent Nos. 10,337,001 and 10,900,034, owned by Agilent Technologies, claimed chemically modified synthetic CRISPR guide RNAs featuring modifications like 2?-O-methyl ...
By encapsulating RNA within a phage-like particle, we enable labs to have confidence in their results at every step. This is not just innovation; it is vital in the fight against H5N1 and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results